Cargando…
The role of pharmaceutical industry in building resilient health system
OBJECTIVES: This study explores the interrelationship among the current sustainability agenda of the pharmaceutical industry, based on the United Nation sustainable development goals (SDGs), the elements of the Joint External Evaluation (JEE) tool, and the triad components of the One Health approach...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751196/ https://www.ncbi.nlm.nih.gov/pubmed/36530653 http://dx.doi.org/10.3389/fpubh.2022.964899 |
_version_ | 1784850419615268864 |
---|---|
author | Saxena, Kanika Balani, Sunita Srivastava, Pallavi |
author_facet | Saxena, Kanika Balani, Sunita Srivastava, Pallavi |
author_sort | Saxena, Kanika |
collection | PubMed |
description | OBJECTIVES: This study explores the interrelationship among the current sustainability agenda of the pharmaceutical industry, based on the United Nation sustainable development goals (SDGs), the elements of the Joint External Evaluation (JEE) tool, and the triad components of the One Health approach. METHODS: A cross-walk exercise was conducted to identify commonalities among SDGs, JEE assessment tool, and One Health approach. An in-depth study of 10 global pharmaceutical firms' corporate sustainability reports and COVID-19 response plan for 2019–2020 was also conducted. RESULTS: The result of the exercise showed the existence of a direct and indirect relationship among the SDGs, elements of JEE assessment tool, and One Health approach. For example, both no poverty (SDG 1) and zero hunger (SDG 2) are linked with food safety targets under the JEE and with human and animal health under the One Health approach. CONCLUSION: This study adds a new dimension emphasizing the possibility of tailoring the pharmaceutical industry's activities under the sustainability agenda to strengthen global health security while remaining consistent with the One Health approach. |
format | Online Article Text |
id | pubmed-9751196 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97511962022-12-16 The role of pharmaceutical industry in building resilient health system Saxena, Kanika Balani, Sunita Srivastava, Pallavi Front Public Health Public Health OBJECTIVES: This study explores the interrelationship among the current sustainability agenda of the pharmaceutical industry, based on the United Nation sustainable development goals (SDGs), the elements of the Joint External Evaluation (JEE) tool, and the triad components of the One Health approach. METHODS: A cross-walk exercise was conducted to identify commonalities among SDGs, JEE assessment tool, and One Health approach. An in-depth study of 10 global pharmaceutical firms' corporate sustainability reports and COVID-19 response plan for 2019–2020 was also conducted. RESULTS: The result of the exercise showed the existence of a direct and indirect relationship among the SDGs, elements of JEE assessment tool, and One Health approach. For example, both no poverty (SDG 1) and zero hunger (SDG 2) are linked with food safety targets under the JEE and with human and animal health under the One Health approach. CONCLUSION: This study adds a new dimension emphasizing the possibility of tailoring the pharmaceutical industry's activities under the sustainability agenda to strengthen global health security while remaining consistent with the One Health approach. Frontiers Media S.A. 2022-12-01 /pmc/articles/PMC9751196/ /pubmed/36530653 http://dx.doi.org/10.3389/fpubh.2022.964899 Text en Copyright © 2022 Saxena, Balani and Srivastava. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Saxena, Kanika Balani, Sunita Srivastava, Pallavi The role of pharmaceutical industry in building resilient health system |
title | The role of pharmaceutical industry in building resilient health system |
title_full | The role of pharmaceutical industry in building resilient health system |
title_fullStr | The role of pharmaceutical industry in building resilient health system |
title_full_unstemmed | The role of pharmaceutical industry in building resilient health system |
title_short | The role of pharmaceutical industry in building resilient health system |
title_sort | role of pharmaceutical industry in building resilient health system |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751196/ https://www.ncbi.nlm.nih.gov/pubmed/36530653 http://dx.doi.org/10.3389/fpubh.2022.964899 |
work_keys_str_mv | AT saxenakanika theroleofpharmaceuticalindustryinbuildingresilienthealthsystem AT balanisunita theroleofpharmaceuticalindustryinbuildingresilienthealthsystem AT srivastavapallavi theroleofpharmaceuticalindustryinbuildingresilienthealthsystem AT saxenakanika roleofpharmaceuticalindustryinbuildingresilienthealthsystem AT balanisunita roleofpharmaceuticalindustryinbuildingresilienthealthsystem AT srivastavapallavi roleofpharmaceuticalindustryinbuildingresilienthealthsystem |